Ependymoma — Trials · CancerIndex

Clinical trials

Registered studies

136 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–136 of 136 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02689336	Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors	withdrawn	Phase 2	0	Washington University School of MedicineOTHER	0	Sep 9, 2019	clinicaltrials
NCT00749723	Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children(HIT-REZ-2005)	completed	Phase 2 / Phase 3	174	University Hospital, BonnOTHER	1	Jul 20, 2018	clinicaltrials
NCT01836549	Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors	terminated	Phase 2	43	Pediatric Brain Tumor ConsortiumNETWORK	1	Jul 20, 2018	clinicaltrials
NCT00919750

Data updated 22 days agoSource updated Sep 9, 2019source: clinicaltrials